CCP COMPOSITES US – Trademark Portfolio
Entity Type: 02
CCP COMPOSITES US holds 33 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 19 filings in this category. The portfolio also extends into Class 2 (Paints) across 4 Nice Classification classes. Currently, 28 trademarks are registered. Notable registered marks include CCP, NUPOL, XYCON, EPOVIA, and IMEDGE. The owner is based in KANSAS CITY, MO.
P.O. BOX 419389
KANSAS CITY, MO 641416389
Showing of trademarks Trademarks
Trademark Classifications
CCP COMPOSITES US's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Paints, varnishes, lacquers; preservatives against rust and against deterioration of wood
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does CCP COMPOSITES US have?
CCP COMPOSITES US has 33 U.S. trademarks filed with the USPTO. Of these, 28 registered, 1 abandoned, 4 cancelled.
What trademark classes does CCP COMPOSITES US file in?
CCP COMPOSITES US files trademarks across 4 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 2 (Paints), Class 3 (Cosmetics & Cleaning), Class 17 (Rubber Goods). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are CCP COMPOSITES US's most well-known trademarks?
CCP COMPOSITES US's registered trademark portfolio includes well-known marks such as CCP, NUPOL, XYCON, EPOVIA, and IMEDGE. These are among 28 currently registered trademarks in the portfolio.
What is CCP COMPOSITES US's trademark registration success rate?
CCP COMPOSITES US has a 85% trademark registration rate, with 28 out of 33 resolved applications resulting in successful registration. Currently, 0 applications are pending review.